Cargando…
Rapidly Progressive and Catastrophic Calciphylaxis After Mechanical Valve Replacement: An Anticoagulation Dilemma
Warfarin is the only approved anticoagulant after mechanical valve replacement, but it is a well described risk factor for calciphylaxis among patients with end-stage kidney disease. Our patient with end-stage kidney disease rapidly developed calciphylaxis after dual mechanical valve replacement in...
Autores principales: | Nyembo, Philippe F., Eidman, Keith E., Simegn, Mengistu, Shaffer, Andrew W., Shroff, Gautam R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666739/ https://www.ncbi.nlm.nih.gov/pubmed/36406917 http://dx.doi.org/10.1016/j.jaccas.2022.07.034 |
Ejemplares similares
-
Sailing between scylla and charybdis—anticoagulation dilemma in a patient with calciphylaxis and mechanical cardiac valve replacement: a case report and literature review
por: Liang, Shichu, et al.
Publicado: (2023) -
Calciphylaxis as a Catastrophic Complication in a Patient with POEMS Syndrome
por: Hineno, Akiyo, et al.
Publicado: (2009) -
Calciphylaxis After Aortic Valve Replacement in a Patient with End-Stage Renal Disease
por: Hirooka, Kazunobu, et al.
Publicado: (2021) -
Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis
por: Russ, Philipp, et al.
Publicado: (2019) -
Anticoagulation dilemma in a high-risk patient with On-X valves
por: Karkar, Ami M., et al.
Publicado: (2015)